{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:54:20Z","timestamp":1768319660582,"version":"3.49.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We hypothesized that exudates collected at the beginning of the resolution phase of inflammation might be enriched for tissue protective molecules; thus an integrated cellular and molecular approach was applied to identify novel chondroprotective bioactions. Exudates were collected 6 h (inflammatory) and 24 h (resolving) following carrageenan-induced pleurisy in rats. The resolving exudate was subjected to gel filtration chromatography followed by proteomics, identifying 61 proteins. Fractions were added to C28\/I2 chondrocytes, grown in micromasses, ions with or without IL-1\u03b2 or osteoarthritic synovial fluids for 48 h. Three proteins were selected from the proteomic analysis, \u03b11-antitrypsin (AAT), hemopexin (HX), and gelsolin (GSN), and tested against catabolic stimulation for their effects on glycosaminoglycan deposition as assessed by Alcian blue staining, and gene expression of key anabolic proteins by real-time PCR. In an in vivo model of inflammatory arthritis, cartilage integrity was determined histologically 48 h after intra-articular injection of AAT or GSN. The resolving exudate displayed protective activities on chondrocytes, using multiple readouts: these effects were retained in low m.w. fractions of the exudate (46.7% increase in glycosaminoglycan deposition; \u223c20% upregulation of COL2A1 and aggrecan mRNA expression), which reversed the effect of IL-1\u03b2. Exogenous administration of HX, GSN, or AAT abrogated the effects of IL-1\u03b2 and osteoarthritic synovial fluids on anabolic gene expression and increased glycosaminoglycan deposition. Intra-articular injection of AAT or GSN protected cartilage integrity in mice with inflammatory arthritis. In summary, the strategy for identification of novel chondroprotective activities in resolving exudates identified HX, GSN and AAT as potential leads for new drug discovery programs.<\/jats:p>","DOI":"10.4049\/jimmunol.1601111","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T01:30:16Z","timestamp":1488245416000},"page":"2876-2885","source":"Crossref","is-referenced-by-count":13,"title":["Identification of Novel Chondroprotective Mediators in Resolving Inflammatory Exudates"],"prefix":"10.1093","volume":"198","author":[{"given":"Magdalena K","family":"Kaneva","sequence":"first","affiliation":[{"name":"William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London , London EC1M 6BQ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin V","family":"Greco","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London , London EC1M 6BQ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4819-7132","authenticated-orcid":false,"given":"Sarah E","family":"Headland","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London , London EC1M 6BQ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trinidad","family":"Montero-Melendez","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London , London EC1M 6BQ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1696-0068","authenticated-orcid":false,"given":"Prashant","family":"Mori","sequence":"additional","affiliation":[{"name":"UCB Celltech , Slough SL1 3WE,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-6611","authenticated-orcid":false,"given":"Kevin","family":"Greenslade","sequence":"additional","affiliation":[{"name":"UCB Celltech , Slough SL1 3WE,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-5051","authenticated-orcid":false,"given":"Costantino","family":"Pitzalis","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London , London EC1M 6BQ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-300X","authenticated-orcid":false,"given":"Adrian","family":"Moore","sequence":"additional","affiliation":[{"name":"UCB Celltech , Slough SL1 3WE,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2068-3331","authenticated-orcid":false,"given":"Mauro","family":"Perretti","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London , London EC1M 6BQ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,4,1]]},"reference":[{"key":"2025030615081429500_r1","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1096\/fj.11-0502ufm","article-title":"The resolution of inflammation: the devil in the flask and in the details","volume":"25","author":"Serhan","year":"2011","journal-title":"FASEB J."},{"key":"2025030615081429500_r2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/emmm.201202382","article-title":"Resolution of inflammation: an integrated view","volume":"5","author":"Ortega-G\u00f3mez","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"2025030615081429500_r3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"2025030615081429500_r4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"2025030615081429500_r5","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1177\/0363546509348840","article-title":"Progressive chondrocyte death after impact injury indicates a need for chondroprotective therapy","volume":"37","author":"Szczodry","year":"2009","journal-title":"Am. J. Sports Med."},{"key":"2025030615081429500_r6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1177\/0363546507307396","article-title":"The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis","volume":"35","author":"Lohmander","year":"2007","journal-title":"Am. J. Sports Med."},{"key":"2025030615081429500_r7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bcp.2014.08.019","article-title":"Melanocortin peptides protect chondrocytes from mechanically induced cartilage injury","volume":"92","author":"Kaneva","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"2025030615081429500_r8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3810\/psm.2014.09.2076","article-title":"The use of platelet-rich plasma for the treatment of osteoarthritis","volume":"42","author":"Jayabalan","year":"2014","journal-title":"Phys. Sportsmed."},{"key":"2025030615081429500_r9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1177\/0363546515575023","article-title":"Stimulation of the superficial zone protein and lubrication in the articular cartilage by human platelet-rich plasma","volume":"43","author":"Sakata","year":"2015","journal-title":"Am. J. Sports Med."},{"key":"2025030615081429500_r10","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.arthro.2015.01.027","article-title":"The addition of platelet-rich plasma to scaffolds used for cartilage repair: a review of human and animal studies","volume":"31","author":"Sermer","year":"2015","journal-title":"Arthroscopy"},{"key":"2025030615081429500_r11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"2025030615081429500_r12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","article-title":"Inducible cyclooxygenase may have anti-inflammatory properties","volume":"5","author":"Gilroy","year":"1999","journal-title":"Nat. Med."},{"key":"2025030615081429500_r13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm0196-87","article-title":"Heme oxygenase: a novel target for the modulation of the inflammatory response","volume":"2","author":"Willis","year":"1996","journal-title":"Nat. Med."},{"key":"2025030615081429500_r14","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1172\/JCI117595","article-title":"Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes","volume":"94","author":"Goldring","year":"1994","journal-title":"J. Clin. Invest."},{"key":"2025030615081429500_r15","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.bcp.2011.09.009","article-title":"High density micromass cultures of a human chondrocyte cell line: a reliable assay system to reveal the modulatory functions of pharmacological agents","volume":"82","author":"Greco","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"2025030615081429500_r16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1432-0436.1996.6050299.x","article-title":"Analysis of chondroprogenitor frequency and cartilage differentiation in a novel family of clonal chondrogenic rat cell lines","volume":"60","author":"Grigoriadis","year":"1996","journal-title":"Differentiation"},{"key":"2025030615081429500_r17","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/endo.137.6.8641167","article-title":"Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers","volume":"137","author":"Lowe","year":"1996","journal-title":"Endocrinology"},{"key":"2025030615081429500_r18","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/jbmr.5650110812","article-title":"Surface adhesion-mediated regulation of chondrocyte-specific gene expression in the nontransformed RCJ 3.1C5.18 rat chondrocyte cell line","volume":"11","author":"McDougall","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"2025030615081429500_r19","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1182\/blood-2008-02-140533","article-title":"Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles","volume":"112","author":"Dalli","year":"2008","journal-title":"Blood"},{"key":"2025030615081429500_r20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2025030615081429500_r21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"2025030615081429500_r22","doi-asserted-by":"crossref","first-page":"315ra190","DOI":"10.1126\/scitranslmed.aac5608","article-title":"Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis","volume":"7","author":"Headland","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"2025030615081429500_r23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2013.01.027","article-title":"An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis","volume":"167","author":"Ryan","year":"2013","journal-title":"J. Control. Release"},{"key":"2025030615081429500_r24","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1136\/annrheumdis-2011-201180","article-title":"The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis","volume":"71","author":"Patel","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"2025030615081429500_r25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000350612","article-title":"Control of myeloid cell trafficking in resolution","volume":"5","author":"Norling","year":"2013","journal-title":"J. Innate Immun."},{"key":"2025030615081429500_r26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/emmm.201201891","article-title":"Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation","volume":"5","author":"Koltsida","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"2025030615081429500_r27","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cub.2014.05.006","article-title":"Resolution mediator chemerin15 reprograms the wound microenvironment to promote repair and reduce scarring. [Published erratum appears in 2014 Curr. Biol. 24: 1435.]","volume":"24","author":"Cash","year":"2014","journal-title":"Curr. Biol."},{"key":"2025030615081429500_r28","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1096\/fj.12-209627","article-title":"Pharmacological blockade of adenosine A2A receptors diminishes scarring","volume":"26","author":"Perez-Aso","year":"2012","journal-title":"FASEB J."},{"key":"2025030615081429500_r29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/CCM.0000000000002014","article-title":"Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes","volume":"45","author":"Dalli","year":"2017","journal-title":"Crit. Care Med."},{"key":"2025030615081429500_r30","doi-asserted-by":"crossref","first-page":"e85922","DOI":"10.1172\/jci.insight.85922","article-title":"Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis","volume":"1","author":"Norling","year":"2016","journal-title":"JCI Insight"},{"key":"2025030615081429500_r31","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins. [Published erratum appears in 2005 J. Immunol. 174: 5884.]","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J. Immunol."},{"key":"2025030615081429500_r32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.joca.2009.11.012","article-title":"Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis","volume":"18","author":"Ruiz-Romero","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"2025030615081429500_r33","doi-asserted-by":"crossref","first-page":"e56246","DOI":"10.1371\/journal.pone.0056246","article-title":"Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach","volume":"8","author":"Biswas","year":"2013","journal-title":"PLoS One"},{"key":"2025030615081429500_r34","doi-asserted-by":"crossref","first-page":"33293","DOI":"10.1074\/jbc.R100016200","article-title":"The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature","volume":"276","author":"Silverman","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2025030615081429500_r35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1172\/JCI110344","article-title":"Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema","volume":"68","author":"Gadek","year":"1981","journal-title":"J. Clin. Invest."},{"key":"2025030615081429500_r36","first-page":"121","article-title":"Inhibition of human granulocyte elastase by serum alpha-1-antitrypsin","volume":"105","author":"Janoff","year":"1972","journal-title":"Am. Rev. Respir. Dis."},{"key":"2025030615081429500_r37","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2119\/molmed.2011.00196","article-title":"Expanding the clinical indications for \u03b1(1)-antitrypsin therapy","volume":"18","author":"Lewis","year":"2012","journal-title":"Mol. Med."},{"key":"2025030615081429500_r38","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1189\/jlb.0108001","article-title":"Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity","volume":"83","author":"Shpacovitch","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"2025030615081429500_r39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00005-012-0162-5","article-title":"Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent","volume":"60","author":"Bergin","year":"2012","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"2025030615081429500_r40","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1073\/pnas.1309648110","article-title":"Anti-inflammatory and immunomodulatory properties of \u03b11-antitrypsin without inhibition of elastase","volume":"110","author":"Jonigk","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030615081429500_r41","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1074\/jbc.M607976200","article-title":"Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP","volume":"282","author":"Janciauskiene","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2025030615081429500_r42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbagen.2005.06.009","article-title":"Aggrecanase-1 (ADAMTS-4) interacts with alpha1-antitrypsin","volume":"1725","author":"Yoshida","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"2025030615081429500_r43","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/annrheumdis-2014-206966","article-title":"Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1\u03b2 and by the induction of endogenous IL-1Ra","volume":"75","author":"Joosten","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"2025030615081429500_r44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1479-5876-9-21","article-title":"Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model","volume":"9","author":"Grimstein","year":"2011","journal-title":"J. Transl. Med."},{"key":"2025030615081429500_r45","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1016\/S0021-9258(17)42985-1","article-title":"Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin","volume":"259","author":"Yin","year":"1984","journal-title":"J. Biol. Chem."},{"key":"2025030615081429500_r46","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00003246-199704000-00007","article-title":"Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis","volume":"25","author":"Suhler","year":"1997","journal-title":"Crit. Care Med."},{"key":"2025030615081429500_r47","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1164\/ajrccm.160.5.9807137","article-title":"Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma","volume":"160","author":"Mounzer","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2025030615081429500_r48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00024382-199908000-00002","article-title":"Plasma gelsolin is reduced in trauma patients","volume":"12","author":"Dahl","year":"1999","journal-title":"Shock"},{"key":"2025030615081429500_r49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.sla.0000201798.77133.55","article-title":"Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients","volume":"243","author":"Lee","year":"2006","journal-title":"Ann. Surg."},{"key":"2025030615081429500_r50","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.CCM.0000253815.26311.24","article-title":"Plasma gelsolin is a marker and therapeutic agent in animal sepsis","volume":"35","author":"Lee","year":"2007","journal-title":"Crit. Care Med."},{"key":"2025030615081429500_r51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1152\/japplphysiol.01074.2002","article-title":"Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction","volume":"96","author":"Rothenbach","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"2025030615081429500_r52","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar2520","article-title":"Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis","volume":"10","author":"Osborn","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"2025030615081429500_r53","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1371\/journal.pgen.0010048","article-title":"Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis. [Published erratum appears in 2005 PLoS Genet. 1: e73.]","volume":"1","author":"Aidinis","year":"2005","journal-title":"PLoS Genet."},{"key":"2025030615081429500_r54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ydbio.2006.09.052","article-title":"Regulation of chondrocyte differentiation by actin-severing protein adseverin","volume":"302","author":"Nurminsky","year":"2007","journal-title":"Dev. Biol."},{"key":"2025030615081429500_r55","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/j.jprot.2011.12.042","article-title":"Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF\/TOF","volume":"75","author":"Mateos","year":"2012","journal-title":"J. Proteomics"},{"key":"2025030615081429500_r56","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/104454902753759717","article-title":"Hemopexin: structure, function, and regulation","volume":"21","author":"Tolosano","year":"2002","journal-title":"DNA Cell Biol."},{"key":"2025030615081429500_r57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1189\/jlb.1208742","article-title":"Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages","volume":"86","author":"Liang","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"2025030615081429500_r58","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1203076","article-title":"Acute-phase protein hemopexin is a negative regulator of Th17 response and experimental autoimmune encephalomyelitis development","volume":"191","author":"Rolla","year":"2013","journal-title":"J. Immunol."},{"key":"2025030615081429500_r59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"2025030615081429500_r60","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.pmrj.2012.02.010","article-title":"Injectable medications for osteoarthritis","volume":"4","author":"Hameed","year":"2012","journal-title":"PM&R"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/198\/7\/2876\/61512250\/1601111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/198\/7\/2876\/61512250\/1601111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T17:22:14Z","timestamp":1741281734000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/198\/7\/2876\/7962199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,1]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1601111","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,4]]},"published":{"date-parts":[[2017,4,1]]}}}